Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

Anne Marie C. Dingemans; Egbert F. Smit; Lizza E.L. Hendriks

doi:10.1056/NEJMc2314327

Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

Anne Marie C. Dingemans^*, Egbert F. Smit, Lizza E.L. Hendriks

^*Corresponding author for this work

Pulmonary Medicine

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

4 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Pages (from-to)	381-382
Number of pages	2
Journal	The New England journal of medicine
Volume	390
Issue number	4
DOIs	https://doi.org/10.1056/NEJMc2314327
Publication status	Published - 25 Jan 2024

Access to Document

10.1056/NEJMc2314327

Selpercatinib or Chemotherapy in RET Fusion–Positive NSCLCFinal published version, 306 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{25f2bd0eb22b421789b0b89743546275,

title = "Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC",

author = "Dingemans, \{Anne Marie C.\} and Smit, \{Egbert F.\} and Hendriks, \{Lizza E.L.\}",

year = "2024",

month = jan,

day = "25",

doi = "10.1056/NEJMc2314327",

language = "English",

volume = "390",

pages = "381--382",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

AU - Dingemans, Anne Marie C.

AU - Smit, Egbert F.

AU - Hendriks, Lizza E.L.

PY - 2024/1/25

Y1 - 2024/1/25

UR - https://www.scopus.com/pages/publications/85183338213

U2 - 10.1056/NEJMc2314327

DO - 10.1056/NEJMc2314327

M3 - Comment/Letter to the editor

C2 - 38265653

AN - SCOPUS:85183338213

SN - 0028-4793

VL - 390

SP - 381

EP - 382

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 4

ER -

Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

Access to Document

Other files and links

Cite this